The orphan G-protein-coupled receptor 75 signaling is activated by the chemokine CCL5

Journal of Neurochemistry
Simona DedoniItalo Mocchetti

Abstract

The chemokine CCL5 prevents neuronal cell death mediated both by amyloid β, as well as the human immunodeficiency virus viral proteins gp120 and Tat. Because CCL5 binds to CCR5, CCR3 and/or CCR1 receptors, it remains unclear which of these receptors plays a role in neuroprotection. Indeed, CCL5 also has neuroprotective activity in cells lacking these receptors. CCL5 may bind to a G-protein-coupled receptor 75 (GPR75), which encodes for a 540 amino-acid orphan receptor of the Gqα family. In this study, we have used SH-SY5Y human neuroblastoma cells to characterize whether CCL5 could activate a Gq signaling through GPR75. Both qPCR and flow cytometry show that these cells express GPR75 but do not express CCR5, CCR3 or CCR1 receptors. SY-SY5Y cells were then used to examine CCL5-mediated signaling. We report that CCL5 promotes a time- and concentration-dependent phosphorylation of protein kinase B (AKT), glycogen synthase kinase 3β, and extracellular signal-regulated kinase (ERK) 1/2. Specific antagonists of CCR5, CCR3, and CCR1 did not prevent CCL5 from increasing phosphorylated AKT or ERK. Moreover, CCL5 promotes a time-dependent internalization of GPR75. Lastly, knocking down GPR75 expression by a CRISPR-Cas9 approach inhibited...Continue Reading

References

Nov 14, 1997·The Journal of Biological Chemistry·A D SchecterM B Taubman
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·O MeucciR J Miller
Jun 25, 1999·Biochemical and Biophysical Research Communications·E E TarttelinC Y Gregory-Evans
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·M Kaul, S A Lipton
Jun 3, 2000·Annual Review of Immunology·D Rossi, A Zlotnik
Jul 24, 2001·The British Journal of Ophthalmology·C G SauerB H Weber
Jul 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Imre SzaboThomas J Rogers
Feb 15, 2005·Brain Research. Brain Research Reviews·Laetitia CartierKarl-Heinz Krause
Feb 26, 2005·Science·Gorazd B StokinLawrence S B Goldstein
Jul 9, 2005·Antiviral Research·Maria T PolianovaMichael R Ruff
Aug 31, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Louis F Reichardt
Dec 16, 2006·Biochimica Et Biophysica Acta·John M Busillo, Jeffrey L Benovic
Jan 12, 2010·Journal of Alzheimer's Disease : JAD·M Paul Murphy, Harry LeVine
Dec 18, 2010·Journal of Neurovirology·Valeriya AvdoshinaItalo Mocchetti
Oct 9, 2012·Neuron·Olivier Civelli
Mar 25, 2014·Annual Review of Immunology·Jason W GriffithAndrew D Luster
Apr 4, 2014·Journal of Molecular Neuroscience : MN·Summer J RozziValeriya Avdoshina
Jul 18, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ricky MaungMarcus Kaul

❮ Previous
Next ❯

Citations

Aug 3, 2018·Journal of Neurochemistry·Barbara Schweitzer, Jörg B Schulz
Jul 8, 2020·Cancers·Donatella AldinucciNaike Casagrande
Dec 24, 2019·Frontiers in Oncology·Jian-Guo ZhouUdo S Gaipl
Oct 6, 2020·Frontiers in Neurology·Ezekiel Gonzalez-FernandezRichard J Roman
Sep 14, 2019·International Journal of Molecular Sciences·Shashank ShekharFan Fan
Oct 21, 2020·International Journal of Molecular Sciences·Jan KorbeckiIrena Baranowska-Bosiacka
Jul 3, 2021·Science·Giles S H Yeo, Stephen O'Rahilly
Aug 11, 2021·Clinical Science·Ezekiel Gonzalez-FernandezRichard J Roman

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.